title: Collagenase injections for treatment of Dupuytren disease.
abstract: Palmodigital fasciectomy remains the gold standard. The initial outcome is, in my experience, far more predictable than either NA or enzyme fasciotomy (EF). It is also a more durable treatment. NA and EF can be conceptualized as similar procedures--one uses a needle and the other an enzyme to weaken a cord sufficient to be able to rupture it and thus straighten a contracted joint. Both are less invasive and the hand is quick to recover. Both procedures are equally initially effective. CHH seems to offer greater durability. Today’s patients are often better educated and seek a specific type of treatment, in particular, effective nonoperative treatment. Pharmaceutical companies now market directly and effectively to patients, and this strategy and Internet use have already resulted in an increase in the number of patients searching for practitioners willing to administer and capable of administering collagenase treatment.
authors.affiliation: Robert A. Chase Center for Hand and Upper Limb Surgery, Stanford University, 770 Welch Road, Suite 400, Palo Alto, CA 94304, USA. Electronic address: vrhentz@stanford.edu.
authors.forename: Vincent R
authors.initials: VR
authors.lastname: Hentz
mesh_terms: D000772:Anesthesia, Local; D017364:Collagenases / Q000008:administration & dosage*; D004387:Dupuytren Contracture / Q000188:drug therapy* / Q000503:physiopathology / Q000534:rehabilitation; D000071938:Fasciotomy; D006801:Humans; D015552:Injections, Intralesional / Q000379:methods; D016059:Range of Motion, Articular; D019233:Retreatment
chemical_list: D017364:Collagenases
keywords: Collagenase; Contracture; Dupuytren; Injection